Charlotte Wilhelmina Wernberg

Søgeresultater

• 2023

  Use of smoc2 as a non biomarker for developing alcoholic or non-alcoholic steatohepatitis

  Graversen, N. J. H. (Opfinder), Chandran, V. I. (Opfinder), Larsen, F. T. (Opfinder), Grøntved, L. (Opfinder), Ravnskjær, K. (Opfinder), Lauridsen, M. E. M. (Opfinder), Wernberg, C. W. (Opfinder) & Krag, A. A. (Opfinder), 14. dec. 2023, IPC nr. G01N33/68, Patentnr. WO2023237529 (A1), Prioritetsdato 7. jun. 2022, Prioritetsnr. EP20220177513

  Publikation: Patent

  • Biological Marker 100%
  • Osteonectin 100%
  • Nonalcoholic Fatty Liver 100%
  • Calcium Binding Protein 100%
  • Reference Level 100%
• 2022

  Use of soluble trem2 as a non-invasive biomarker for non-alcoholic steatohepatitis (NASH)

  Graversen, N. J. H. (Opfinder), Chandran, V. I. (Opfinder), Moestrup, S. K. (Opfinder), Skytthe, M. K. (Opfinder), Krag, A. A. (Opfinder), Wernberg, C. (Opfinder) & Lauridsen, M. E. M. (Opfinder), 1. dec. 2022, IPC nr. G01N 33/ 68 , Patentnr. WO2022248363, Prioritetsdato 28. maj 2021, Prioritetsnr. EP20210176575

  Publikation: Patent

  • Biological Marker 100%
  • Nonalcoholic Fatty Liver 100%
  • Inflammation 33%
  • Fibrosis 33%

• Use of soluble TREM2 as non-invasive biomarker for NASH

  Graversen, J. H. (Opfinder), Chandran, V. I. (Opfinder), Moestrup, S. K. (Opfinder), Skytthe, M. K. (Opfinder), Krag, A. (Opfinder), Wernberg, C. (Opfinder) & Lauridsen, M. (Opfinder), 1. dec. 2022, IPC nr. G01N33/68, Patentnr. WO2022248363 (A1) , Prioritetsdato 28. maj 2021, Prioritetsnr. EP20210176575

  Publikation: Patent

  • Biological Marker 100%
  • TREM2 100%
  • Blood Plasma 50%
  • Inflammation 33%
  • Fibrosis 33%

• Use of sparc-related modular calcium binding protein 2 as a non-invasive biomarker

  Graversen, J. H. (Opfinder), Chandran, V. I. (Opfinder), Larsen, F. T. (Opfinder), Grøntved, L. (Opfinder), Ravnskjær, K. (Opfinder), Lauridsen, M. (Opfinder), Wernberg, C. (Opfinder) & Krag, A. (Opfinder), 2022, Patentnr. EP22177513.3

  Publikation: Patent